• Products
  • Preclinical
  • Phase 1/2
  • Phase 3
  • Marketed
  • TPM®/Diclofenac GelSigns and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitisNovartis & Themis Medicare have marketing rights for India
  •  
  •  
  •  
  •  
  •  
  • TPM®/Lidocaine GelItching, burning, and pain due to skin inflammationNone
  •  
  •  
  •  
  •  
  •  
  • TPM®/Propofol Injectable EmulsionAnesthesiaNone
  •  
  •  
  •  
  •  
  •  
  • TPM®/Antibiotic* Lyophilized Powder for IV InjectionComplicated skin and skin structure infections (cSSSI)Mylan has worldwide marketing rights
  •  
  •  
  •  
  •  
  •  
  • TPM®/Ibuprofen GelTopical treatment of acute pain due to minor strains, sprains, and contusionsNone
  •  
  •  
  •  
  •  
  •  

Note: all development phases are not applicable for 505(b)2 regulatory filings in the USA, or similar filings in other jurisdictions
* This molecule cannot be disclosed for confidentiality reasons; this product has been licensed but not yet launched by Mylan